全文获取类型
收费全文 | 78087篇 |
免费 | 5704篇 |
国内免费 | 1695篇 |
专业分类
耳鼻咽喉 | 3102篇 |
儿科学 | 947篇 |
妇产科学 | 1757篇 |
基础医学 | 1958篇 |
口腔科学 | 3167篇 |
临床医学 | 7321篇 |
内科学 | 7267篇 |
皮肤病学 | 724篇 |
神经病学 | 2660篇 |
特种医学 | 1281篇 |
外国民族医学 | 20篇 |
外科学 | 26617篇 |
综合类 | 10852篇 |
现状与发展 | 6篇 |
一般理论 | 2篇 |
预防医学 | 2890篇 |
眼科学 | 4620篇 |
药学 | 3295篇 |
173篇 | |
中国医学 | 1293篇 |
肿瘤学 | 5534篇 |
出版年
2024年 | 89篇 |
2023年 | 2055篇 |
2022年 | 2482篇 |
2021年 | 4021篇 |
2020年 | 4314篇 |
2019年 | 3674篇 |
2018年 | 3510篇 |
2017年 | 3089篇 |
2016年 | 3058篇 |
2015年 | 3080篇 |
2014年 | 6087篇 |
2013年 | 5654篇 |
2012年 | 4601篇 |
2011年 | 4814篇 |
2010年 | 3805篇 |
2009年 | 3579篇 |
2008年 | 3442篇 |
2007年 | 3410篇 |
2006年 | 2982篇 |
2005年 | 2601篇 |
2004年 | 2263篇 |
2003年 | 1837篇 |
2002年 | 1417篇 |
2001年 | 1357篇 |
2000年 | 1161篇 |
1999年 | 1063篇 |
1998年 | 843篇 |
1997年 | 771篇 |
1996年 | 567篇 |
1995年 | 512篇 |
1994年 | 443篇 |
1993年 | 360篇 |
1992年 | 308篇 |
1991年 | 302篇 |
1990年 | 204篇 |
1989年 | 205篇 |
1988年 | 206篇 |
1987年 | 201篇 |
1986年 | 164篇 |
1985年 | 178篇 |
1984年 | 165篇 |
1983年 | 115篇 |
1982年 | 119篇 |
1981年 | 101篇 |
1980年 | 81篇 |
1979年 | 45篇 |
1978年 | 40篇 |
1977年 | 36篇 |
1976年 | 29篇 |
1975年 | 23篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
51.
Malou A.H. Nuijten Thijs M.H. Eijsvogels Valerie M. Monpellier Ignace M.C. Janssen Eric J. Hazebroek Maria T.E. Hopman 《Obesity reviews》2022,23(1):e13370
Postbariatric loss of muscle tissue could negatively affect long-term health due to its role in various bodily processes, such as metabolism and functional capacity. This meta-analysis aimed to unravel time-dependent changes in the magnitude and progress of lean body mass (LBM), fat-free mass (FFM), and skeletal muscle mass (SMM) loss following bariatric surgery. A systematic literature search was conducted in Pubmed, Embase, and Web of Science. Fifty-nine studies assessed LBM (n = 37), FFM (n = 20), or SMM (n = 3) preoperatively and ≥1 time points postsurgery. Random-effects meta-analyses were performed to determine pooled loss per outcome parameter and follow-up time point. At 12-month postsurgery, pooled LBM loss was ?8.13 kg [95%CI ?9.01; ?7.26]. FFM loss and SMM loss were ?8.23 kg [95%CI ?10.74; ?5.73] and ?3.18 kg [95%CI ?5.64; ?0.71], respectively. About 55% of 12-month LBM loss occurred within 3-month postsurgery, followed by a more gradual decrease up to 12 months. Similar patterns were seen for FFM and SMM. In conclusion, >8 kg of LBM and FFM loss was observed within 1-year postsurgery. LBM, FFM, and SMM were predominantly lost within 3-month postsurgery, highlighting that interventions to mitigate such losses should be implemented perioperatively. 相似文献
52.
《The British journal of oral & maxillofacial surgery》2022,60(7):991-993
An accurate transfer of a 3D virtual planned proportional condylectomy to the patient is challenging due to the limited surgical access. A new clinical workflow that uses augmented reality to assist a condylectomy is presented step-by-step. This AR-based approach has the potential to be implemented in the clinical setting routinely. 相似文献
53.
54.
J. M. Nolde M. P. Schlaich D. I. Sessler A. Mian T. B. Corcoran C. K. Chow M. T. V. Chan F. K. Borges M. H. McGillion P. S. Myles N. L. Mills P. J. Devereaux G. S. Hillis 《Anaesthesia》2023,78(7):853-860
Myocardial injury due to ischaemia within 30 days of non-cardiac surgery is prognostically relevant. We aimed to determine the discrimination, calibration, accuracy, sensitivity and specificity of single-layer and multiple-layer neural networks for myocardial injury and death within 30 postoperative days. We analysed data from 24,589 participants in the Vascular Events in Non-cardiac Surgery Patients Cohort Evaluation study. Validation was performed on a randomly selected subset of the study population. Discrimination for myocardial injury by single-layer vs. multiple-layer models generated areas (95%CI) under the receiver operating characteristic curve of: 0.70 (0.69–0.72) vs. 0.71 (0.70–0.73) with variables available before surgical referral, p < 0.001; 0.73 (0.72–0.75) vs. 0.75 (0.74–0.76) with additional variables available on admission, but before surgery, p < 0.001; and 0.76 (0.75–0.77) vs. 0.77 (0.76–0.78) with the addition of subsequent variables, p < 0.001. Discrimination for death by single-layer vs. multiple-layer models generated areas (95%CI) under the receiver operating characteristic curve of: 0.71 (0.66–0.76) vs. 0.74 (0.71–0.77) with variables available before surgical referral, p = 0.04; 0.78 (0.73–0.82) vs. 0.83 (0.79–0.86) with additional variables available on admission but before surgery, p = 0.01; and 0.87 (0.83–0.89) vs. 0.87 (0.85–0.90) with the addition of subsequent variables, p = 0.52. The accuracy of the multiple-layer model for myocardial injury and death with all variables was 70% and 89%, respectively. 相似文献
55.
目的 探讨协同式早期运动干预在腹腔镜结直肠癌手术患者中的应用效果。方法 使用随机数字表法将2020年5月-2021年5月于笔者所在医院进行腹腔镜结直肠癌手术的84例患者分为对照组和干预组,各42例。对照组术后采用常规运动干预,干预组术后采用协同式早期运动干预。比较2组术后恢复情况、身体状况、术后并发症发生情况。结果 干预组首次下床活动时间、术后排气时间、术后排便时间均早于对照组(χ2=11.823,P=0.001;χ2=4.687,P=0.001;χ2=7.611,P=0.001),术后7d干预组的多维度疲劳量表评分低于对照组(t=2.000,P=0.049),杜克活动指数高于对照组(t=2.256,P=0.027),2组术后并发症发生率比较,差异无统计学意义(χ2=0.343,P=0.558)。结论 协同式早期运动干预能够促进腹腔镜结直肠癌手术患者术后恢复,改善身体状况,值得推广应用。 相似文献
56.
目的观察分析眼球钝挫伤合并外伤性晶状体脱位患者周边隐匿性视网膜病变的临床特点及预后。 方法本研究纳入2013年1月至2020年1月在柳州市人民医院眼科住院诊断为眼球钝挫伤合并外伤性晶状体脱位,并行23G微创玻璃体切割联合白内障摘除手术的72例(72眼)患者。根据裂隙灯和超声生物显微镜(UBM)检查,将患者分为晶状体不全脱位组和全脱位组,详细记录2组患者的术中周边视网膜病变情况,并分析其临床特征及疗效。 结果眼球钝挫伤合并外伤性晶状体脱位患者中有周边隐匿性视网膜病变的占72.22%,其中晶状体不全脱位组发生率高达80.95%,显著大于晶状体全脱位组的60.00%(P<0.05)。2组患者的周边隐匿性视网膜病变均以隐匿性视网膜裂孔、变性和出血为最常见。所有患者术后视网膜情况稳定,视力预后较好。 结论眼球钝挫伤合并外伤性晶状体脱位患者常出现周边隐匿性视网膜病变,最常见的是视网膜裂孔、出血、变性。23G微创玻璃体切割联合白内障摘除手术是有效治疗手段,具有创伤小、并发症少的优势。 相似文献
57.
K. El-Boghdadly T. M. Cook T. Goodacre J. Kua S. Denmark S. McNally N. Mercer S. R. Moonesinghe D. J. Summerton 《Anaesthesia》2022,77(5):580-587
The impact of vaccination and new SARS-CoV-2 variants on peri-operative outcomes is unclear. We aimed to update previously published consensus recommendations on timing of elective surgery after SARS-CoV-2 infection to assist policymakers, administrative staff, clinicians and patients. The guidance remains that patients should avoid elective surgery within 7 weeks of infection, unless the benefits of doing so exceed the risk of waiting. We recommend individualised multidisciplinary risk assessment for patients requiring elective surgery within 7 weeks of SARS-CoV-2 infection. This should include baseline mortality risk calculation and assessment of risk modifiers (patient factors; SARS-CoV-2 infection; surgical factors). Asymptomatic SARS-CoV-2 infection with previous variants increased peri-operative mortality risk three-fold throughout the 6 weeks after infection, and assumptions that asymptomatic or mildly symptomatic omicron SARS-CoV-2 infection does not add risk are currently unfounded. Patients with persistent symptoms and those with moderate-to-severe COVID-19 may require a longer delay than 7 weeks. Elective surgery should not take place within 10 days of diagnosis of SARS-CoV-2 infection, predominantly because the patient may be infectious, which is a risk to surgical pathways, staff and other patients. We now emphasise that timing of surgery should include the assessment of baseline and increased risk, optimising vaccination and functional status, and shared decision-making. While these recommendations focus on the omicron variant and current evidence, the principles may also be of relevance to future variants. As further data emerge, these recommendations may be revised. 相似文献
58.
《台湾医志》2022,121(11):2237-2247
59.
60.
Comprehensive evidence regarding the treatment of non-anaemic iron deficiency in patients undergoing valvular heart surgery is lacking. This study aimed to investigate the association between non-anaemic iron deficiency and postoperative outcomes in these patients. We retrospectively analysed 321 patients of which 180 (56%) had iron deficiency (defined as serum ferritin < 100 ng.ml-1 or < 300 ng.ml-1 with transferrin saturation < 20%). While the iron-deficient group had lower pre-operative haemoglobin levels than the non-iron deficient group (median (IQR [range]) 134 (127–141 [120–172]) g.l-1, 143 (133–150 [120–179]) g.l-1, p = 0.001), there was no between-group difference in allogeneic red blood cell transfusion. Median (IQR [range]) days alive and out of hospital at postoperative day 90 was 1 day shorter in the iron-deficient group (80 (77–82 [9–85]) days vs. 81 (79–83 [0–85]) days, p = 0.026). In multivariable analysis, only cardiopulmonary bypass duration (p = 0.032) and intra-operative allogeneic red blood cell transfusion (p = 0.011) were significantly associated with reduced days alive and out of hospital at postoperative day 90. Iron deficiency did not exert any adverse influence on secondary outcomes except length of hospital stay. Our findings indicate that non-anaemic iron deficiency alone is not associated with adverse effects in patients undergoing valvular heart surgery when it does not translate into an increased risk of allogeneic transfusion. 相似文献